Latest Articles
Global Endometriosis Treatment Market to Reach USD 6,297.2 Million by 2035 at a 5.4% of CAGR - PharmiWeb.com
Global Endometriosis Treatment Market to Reach USD 6,297.2 Million by 2035 at a 5.4% of CAGR PharmiWeb.com
Published: Feb. 25, 2025, 4:05 p.m.
How Robotic Surgery is Transforming Endometriosis Treatment - Healthcare Radius
How Robotic Surgery is Transforming Endometriosis Treatment Healthcare Radius
Published: Feb. 7, 2025, 7:16 a.m.
Robotic surgery is revolutionizing endometriosis treatment and improving fertility: Experts - Healthcare Radius
Robotic surgery is revolutionizing endometriosis treatment and improving fertility: Experts Healthcare Radius
Published: Feb. 7, 2025, 7:16 a.m.
Mitochondrial dynamics: molecular mechanism and implications in endometriosis.
Endometriosis affects about 10% of women of reproductive age, leading to a disabling gynecologic condition. Chronic pain, inflammation, and oxidative stress have been identified as the molecular pathways involved in …
Published: Jan. 28, 2025, midnight
Central Serous Chorioretinopathy in Endometriosis Treatment with Progestogen: A Metabolic Understanding.
Endometriosis afflicts 10% of women in their reproductive years and nearly half of women with infertility, and its etiology is not yet clear. Pharmacological therapy is generally based on progestins …
Published: Jan. 22, 2025, midnight
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR - EIN News
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR EIN News
Published: Jan. 21, 2025, 10:38 a.m.
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR - ABN Newswire
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR ABN Newswire
Published: Jan. 21, 2025, 12:38 a.m.
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment Femtech Insider
Published: Jan. 20, 2025, 10:56 a.m.
Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment - beQuoted
Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment beQuoted
Published: Jan. 20, 2025, 8:21 a.m.
BEYOND THE SCALPEL: ROBOTIC SURGERY INNOVATES FIBROIDS, ENDOMETRIOSIS TREATMENT - The Star Online
BEYOND THE SCALPEL: ROBOTIC SURGERY INNOVATES FIBROIDS, ENDOMETRIOSIS TREATMENT The Star Online
Published: Jan. 19, 2025, 12:36 a.m.
Link copied to clipboard!